The Bow Foundation launched the GNAO1 International Patient Registry to accelerate medical research into meaningful health outcomes for GNAO1-related neurodevelopmental disorders. The registry is a key step towards establishing a better understanding of GNAO1 disorders. The registry will:
- Allow researchers to focus on new studies to address the most important GNAO1 challenges.
- Provide valuable information for families and doctors looking to make the best care decisions for loved ones.
- Help scientists locate GNAO1 patients who might be candidates for their research studies.